Examining sleep disorders in Parkinson's disease and related conditions
Official title: Controlled, Multicenter Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
Run by Assistance Publique - Hôpitaux de Paris · NCT06582121 · Data updated 2026-11-12
This study is testing how sleep problems affect people with Parkinson's disease and REM sleep behavior disorder to better understand their sleep patterns.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 457 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 6 sites (Clermont-Ferrand and 5 other locations) |
| Status | Recruiting |
| Started | March 18, 2025 |
| Main results expected | April 2028 |
| Study ends | April 2028 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT06582121 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with a diagnosis of Parkinson's disease or isolated REM sleep behavior disorder.
✕Probably not a fit
Patients with progressive neurodegenerative diseases other than isolated RBD or Parkinson's disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates sleep disturbances in patients with isolated REM Behavior Disorder and Parkinson's disease. It aims to systematically assess the clinical characteristics and electrophysiological patterns of major sleep disorders associated with these conditions. Participants will undergo polysomnography to gather detailed sleep data. The study includes individuals diagnosed with Parkinson's disease, those with REM sleep behavior disorder, and healthy controls for comparison.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of sleep disorders in patients with Parkinson's disease.
How similar studies have gone: Other studies have explored sleep disorders in Parkinson's disease, but this specific approach focusing on isolated RBD is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Common to all groups: * Age superior 18 years * Patients who have received complete information about the study from an investigator and who fully consent to participate. For Parkinson Disease (PD): * Patients followed for PD diagnosed according to international criteria for the diagnosis of PD (MDS criteria), * A MoCA score greater than 20/30 * No treatment with deep brain stimulation. For REM Sleep Behavior Disorder (RBD): * Diagnosis of RBD according to ICSD-3 criteria: presence on polysomnography of an abnormal elevation of muscle tone during REM sleep (more than 18% of REM sleep without chin atonia) and/or the presence of REM sleep behaviors on video-polysomnography, * Absence of progressive neurodegenerative pathology: absence of diagnostic criteria for PD, multiple system atrophy, or Lewy body dementia. For healthy controls: \- No neurological or psychiatric disease Exclusion Criteria: Common to all groups: * Pregnant or breastfeeding women * Subjects under guardianship/conservatorship * Persons deprived of liberty.
Where it's running
-
CHU de Clermont-Ferrand
Clermont-Ferrand, France Recruiting -
CHU de Lille
Lille, France Recruiting -
CHU de Lyon
Lyon, France Recruiting -
CHU de Nantes
Nantes, France Recruiting -
CHU de Nîmes
Nîmes, France Recruiting -
CHU Pitié Salpêtrière
Paris, France Recruiting
Study contacts
- Study coordinator: Isabelle ARNULF, Prof
- Email: isabelle.arnulf@aphp.fr
- Phone: +33 (0)1 42 16 77 04
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Gentle nighttime sounds to boost deep sleep and slow brain changes in iRBD and early Parkinson's
This test will see if playing gentle sounds during sleep can boost deep slow-wave sleep and slow brain changes in people with isolated REM sleep behavior disorder or early Parkinson's disease.
-
Imaging inflammation in Parkinson's disease using PET scans
This study is testing how inflammation affects Parkinson's disease by using special scans and blood tests to see what happens when participants are given a mild inflammatory substance.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.